Insider · CIK 0001532233

Bernick Brian

Reports to the SEC for 1 company · BOCA RATON, FL

sec.gov

Transactions

Companies

Filings

CIK

0001532233

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-12-09	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−320 sh	$6.31	−$2,019.872	3,872
2022-12-06	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+3,167 sh	—	—	5,127
2022-12-06	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−935 sh	$4.92	−$4,601.603	4,192
2022-12-06	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−3,167 sh	—	—	10,517
2019-10-25	TXMDTherapeuticsMD, Inc.P Purchase	Co-Chief Executive Officer	PPurchase	+36K sh	$2.75	+$99K	98,000
2019-08-28	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Co-Chief Executive Officer	AAward	+300K sh	—	—	300,000
2019-08-09	TXMDTherapeuticsMD, Inc.P Purchase	Co-Chief Executive Officer	PPurchase	+10K sh	$2.87	+$28.7K	62,000
2018-12-13	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.9K sh	$0.10	+$9,356.438	6,649,281
2018-12-13	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.9K sh	$4.12	−$379K	6,557,371
2018-12-13	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.9K sh	—	—	0
2018-12-12	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-12-12	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$4.18	−$382K	6,557,371
2018-12-12	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	91,910
2018-12-07	TXMDTherapeuticsMD, Inc.G Gift	Co-Chief Executive Officer	GGift	−190K sh	—	—	52,000
2018-12-03	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-12-03	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$5.18	−$473K	6,557,371
2018-12-03	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	183,310
2018-11-30	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-11-30	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$4.96	−$453K	6,557,371
2018-11-30	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	274,710
2018-11-20	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-11-20	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$4.74	−$433K	6,557,371
2018-11-20	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	366,110
2018-11-19	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-11-19	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$4.75	−$434K	6,557,371
2018-11-19	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	457,510
2018-11-09	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-11-09	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$4.83	−$441K	6,557,371
2018-11-09	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	548,100
2018-11-08	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-11-08	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$4.93	−$450K	6,557,371
2018-11-08	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	640,310
2018-10-19	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-10-19	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$5.51	−$504K	6,557,371
2018-10-19	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	731,710
2018-10-18	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-10-18	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$5.61	−$513K	6,557,371
2018-10-18	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	823,110
2018-10-05	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-10-05	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$5.93	−$542K	6,557,371
2018-10-05	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	914,510
2018-10-04	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-10-04	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$5.89	−$538K	6,557,371
2018-10-04	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	1,005,910
2018-09-28	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-09-28	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$6.55	−$599K	6,557,371
2018-09-28	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	1,097,310
2018-09-27	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	+91.4K sh	$0.10	+$9,304.52	6,648,771
2018-09-27	TXMDTherapeuticsMD, Inc.S Sale	Co-Chief Executive Officer	SSale	−91.4K sh	$6.63	−$606K	6,557,371
2018-09-27	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Co-Chief Executive Officer	MExercise/Conversion	−91.4K sh	—	—	1,188,710

Recent filings

Accepted (ET)
Dec 94
Bernick Brian0001209191-22-060588
SEC(opens sec.gov)
Oct 294
Bernick Brian0001387131-19-007989
SEC(opens sec.gov)
Aug 304
Bernick Brian0001387131-19-006604
SEC(opens sec.gov)
Aug 134
Bernick Brian0001387131-19-006033
SEC(opens sec.gov)
Dec 144
Bernick Brian0001387131-18-006797
SEC(opens sec.gov)
Dec 44
Bernick Brian0001387131-18-006595
SEC(opens sec.gov)

Companies

TherapeuticsMD, Inc.Co-Chief Executive OfficerTXMD

Address

951 BROKEN SOUND PARKWAY NW SUITE 320

BOCA RATON, FL, 33487